Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina

Clinical and Experimental Ophthalmology

Volumn 41, Issue 6, 2013, Pages 582-592

  Mclenachan, Samuel ^a,b   Chen, Xiangting ^c   Mcmenamin, Paul G ^c   Rakoczy, Elizabeth P ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Diabetes; Ins2Akita; Retinopathy

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; RESIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FLUORESCENCE ANGIOGRAPHY; HYPERGLYCEMIA; MOUSE; MUELLER CELL; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PROTEIN EXPRESSION; RETINA; RETINAL THICKNESS; SCANNING LASER OPHTHALMOSCOPY;

DIABETES; INS2AKITA; RETINOPATHY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FROZEN SECTIONS; GENOTYPE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOGLOBIN A, GLYCOSYLATED; INSULIN; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; NERVE TISSUE PROTEINS; NEUROGLIA; OPHTHALMOSCOPY; POINT MUTATION; POLYMERASE CHAIN REACTION; RETINAL VESSELS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84881115282     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12084     Document Type: Article

References (38)

1. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 2007; 14: 179-183.
2. Aiello LP, Gardner TW, King GL etal. Diabetic retinopathy. Diabetes Care 1998; 21: 143-156.
3. Kempen JH, O'Colmain BJ, Leske MC etal. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 2004; 122: 552-563.
4. Deeds MC, Anderson JM, Armstrong AS etal. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab Anim 2011; 45: 131-140.
5. Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep 1963; 29 (Pt 1): 91-98.
6. Ozawa Y, Kurihara T, Sasaki M etal. Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model. Exp Diabetes Res 2011; 2011: 108328 7 pages.
7. Yoshioka M, Kayo T, Ikeda T, Koizumi A. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997; 46: 887-894.
8. Barber AJ, Antonetti DA, Kern TS etal. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 2210-2218.
9. Smith SB, Duplantier J, Dun Y etal. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci 2008; 49: 4154-4161.
10. Krady JK, Basu A, Allen CM etal. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005; 54: 1559-1565.
11. Maia OO Jr, Takahashi BS, Costa RA, Scott IU, Takahashi WY. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema: one-year results of a randomized clinical trial. Am J Ophthalmol 2009; 147: 291-7.e2.
12. Muehlhoefer A, Saubermann LJ, Gu X etal. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 2000; 164: 3368-3376.
13. Luhmann UFO, Lange CA, Robbie S etal. Differential modulation of retinal degeneration by Ccl2 and Cx3cr1 chemokine signalling. PLoS ONE 2012; 7: e35551.
14. Mattapallil MJ, Wawrousek EF, Chan C-C etal. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 2012; 53: 2921-2927.
15. Mehalow AK, Kameya S, Smith RS etal. CRB1 is essential for external limiting membrane integrity and photoreceptor morphogenesis in the mammalian retina. Hum Mol Genet 2003; 12: 2179-2189.
16. Rakoczy EP, Ali Rahman IS, Binz N etal. Characterization of a mouse model of hyperglycemia and retinal neovascularization. Am J Pathol 2010; 177: 2659-2670.
17. Ali Rahman IS, Li CR, Lai CM, Rakoczy EP. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization. Curr Eye Res 2011; 36: 654-662.
18. McMenamin PG. Optimal methods for preparation and immunostaining of iris, ciliary body, and choroidal wholemounts. Invest Ophthalmol Vis Sci 2000; 41: 3043-3048.
19. Vagaja NN, Chinnery HR, Binz N, Kezic JM, Rakoczy EP, McMenamin PG. Changes in murine hyalocytes are valuable early indicators of ocular disease. Invest Ophthalmol Vis Sci 2012; 53: 1445-1451.
20. Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG. Dendritic cell physiology and function in the eye. Immunol Rev 2010; 234: 282-304.
21. Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 2010; 215: 685-691.
22. Provis JM, Diaz CM, Penfold PL. Microglia in human retina: a heterogeneous population with distinct ontogenies. Perspect Dev Neurobiol 1996; 3: 213-222.
23. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000; 41: 3561-3568.
24. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998; 102: 783-791.
25. Gaucher D, Chiappore JA, Paques M etal. Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res 2007; 47: 612-623.
26. Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis Neurosci 2000; 17: 463-471.
27. Chihara E, Matsuoka T, Ogura Y, Matsumura M. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 1993; 100: 1147-1151.
28. Lopes de Faria JM, Russ H, Costa VP. Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol 2002; 86: 725-728.
29. van Dijk HW, Kok PH, Garvin M etal. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 3404-3409.
30. van Dijk HW, Verbraak FD, Kok PH etal. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci 2010; 51: 3660-3665.
31. van Dijk HW, Verbraak FD, Stehouwer M etal. Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy. Vision Res 2011; 51: 224-228.
32. Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52: 1156-1163.
33. Gastinger MJ, Singh RS, Barber AJ. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas. Invest Ophthalmol Vis Sci 2006; 47: 3143-3150.
34. Huang H, Gandhi JK, Zhong X etal. TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci 2011; 52: 1336-1344.
35. Bringmann A, Iandiev I, Pannicke T etal. Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009; 28: 423-451.
36. Zong H, Ward M, Madden A etal. Hyperglycaemia-induced pro-inflammatory responses by retinal Muller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 2010; 53: 2656-2666.
37. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998; 47: 445-449.
38. Akimov NP, Renteria RC. Spatial frequency threshold and contrast sensitivity of an optomotor behavior are impaired in the Ins2(Akita) mouse model of diabetes. Behav Brain Res 2012; 226: 601-605.